TG Therapeutics Inc (TGTX)

Quick ratio

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash	US$ in thousands	195,822	82,910	75,477	92,933	150,902	97,009	61,469	102,304	109,860	147,073	185,676	298,887	326,512	401,707	471,514	553,439	254,154	260,512	52,051	112,637
Short-term investments	US$ in thousands	145,219	134,342	134,308	124,575	78,257	47,896	78,241	59,374	66,082	48,636	47,525	15,876	30,338	41,752	52,334	51,987	46	15,058	26,284	27,798
Receivables	US$ in thousands	115,727	83,608	64,982	51,093	39,320	17,484	8,623	0	—	88	903	1,389	1,384	931	771	—	—	—	—	—
Total current liabilities	US$ in thousands	125,114	108,664	99,684	53,720	57,678	72,667	63,076	53,201	36,447	43,326	54,656	65,384	87,655	87,551	92,494	87,554	77,670	67,537	63,118	84,449
Quick ratio		3.65	2.77	2.76	5.00	4.65	2.23	2.35	3.04	4.83	4.52	4.28	4.84	4.09	5.08	5.67	6.91	3.27	4.08	1.24	1.66

September 30, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($195,822K + $145,219K + $115,727K) ÷ $125,114K
= 3.65

The quick ratio of TG Therapeutics Inc has been fluctuating over the past few quarters. The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. A higher quick ratio indicates a stronger liquidity position.

As of September 30, 2024, the quick ratio stood at 3.65, which indicates that the company had $3.65 in liquid assets available to cover each dollar of its current liabilities. This suggests that TG Therapeutics Inc had a robust liquidity position at the end of the most recent quarter.

Looking at the historical trend, the quick ratio has shown variability, with values ranging from a low of 1.24 in March 2020 to a high of 6.91 in December 2020. The company experienced a significant increase in liquidity between December 2020 and March 2021, with the quick ratio jumping from 6.91 to 5.67.

Overall, despite fluctuations, the quick ratio of TG Therapeutics Inc has generally been above 1, indicating that the company has had sufficient liquid assets to cover its short-term obligations throughout the periods examined. High and stable quick ratios suggest a strong liquidity position and the ability to meet short-term financial obligations effectively.